Search Results

By The ASCO Post Staff  / Thursday, September 10, 2015 10:56 AM

WCLC: Effect of EGFR Protein and EGFR Gene Copy Number in SQUIRE Trial

Previously, researchers reporting on the SQUIRE study demonstrated that the addition of necitumumab to gemcitabine-cisplatin improved overall survival in patients with stage IV squamous non–small cell lung cancer (NSCLC). Following up on these findings, Fred R. Hirsch, MD, PhD,...